G1 Therapeutics (GTHX) P/FCF US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -8.14 | -3.24 | -1.83 | -1.83 | -4.12 | -2.25 | |||
Changes by years, y/y, % | -16% | -60% | -43% | 0% | +124% | -13.5% |
G1 Therapeutics. P/FCF
G1 Therapeutics. P/FCF, changes, %
G1 Therapeutics (GTHX) P/FCF US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/FCF | -1.92 | -1.33 | -4.12 | -12.4 | -3.19 | -2.25 | ||
Changes by years, y/y, % | +33% | -67% | +112% | +975% | +66% | |||
Changes by quarters, q/q, % | +67% | -31% | +211% | +201% | -74% |